Axxcess Wealth Management LLC purchased a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 2,435 shares of the exchange traded fund’s stock, valued at approximately $217,000.
Other hedge funds also recently bought and sold shares of the company. EPG Wealth Management LLC increased its stake in shares of SPDR S&P Biotech ETF by 152.7% during the third quarter. EPG Wealth Management LLC now owns 460 shares of the exchange traded fund’s stock worth $34,000 after purchasing an additional 278 shares in the last quarter. Tennessee Valley Asset Management Partners purchased a new stake in SPDR S&P Biotech ETF during the 4th quarter worth approximately $44,000. Wetzel Investment Advisors Inc. acquired a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at approximately $45,000. Life Planning Partners Inc purchased a new position in shares of SPDR S&P Biotech ETF in the fourth quarter valued at approximately $64,000. Finally, Albion Financial Group UT purchased a new position in shares of SPDR S&P Biotech ETF in the fourth quarter valued at approximately $69,000.
SPDR S&P Biotech ETF Stock Performance
Shares of XBI opened at $89.02 on Friday. The stock has a 50 day moving average price of $91.25 and a 200 day moving average price of $85.82. SPDR S&P Biotech ETF has a one year low of $63.80 and a one year high of $103.52. The stock has a market capitalization of $6.79 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Recommended Stories
- Five stocks we like better than SPDR S&P Biotech ETF
- 3 Small Caps With Big Return Potential
- Will the Biotech Sector Shift From Lagger to Leader?
- What is a Secondary Public Offering? What Investors Need to Know
- Robinhood Soars: Dissecting a Record-Breaking Q1 2024
- 3 Monster Growth Stocks to Buy Now
- Plug Power is Building the Future of Hydrogen Despite Headwinds
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.